AtriCure, Inc.ATRCNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank41
5Y CAGR-68.6%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
-68.6%/yr
Long-term compound
Percentile
P41
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.14% |
| Q3 2025 | -0.20% |
| Q2 2025 | 3.07% |
| Q1 2025 | 5.36% |
| Q4 2024 | -1.44% |
| Q3 2024 | -0.49% |
| Q2 2024 | 2.78% |
| Q1 2024 | 6.95% |
| Q4 2023 | 8.68% |
| Q3 2023 | -3.42% |
| Q2 2023 | 6.19% |
| Q1 2023 | 8.22% |
| Q4 2022 | -3.08% |
| Q3 2022 | -8.21% |
| Q2 2022 | 11.18% |
| Q1 2022 | 4.48% |
| Q4 2021 | 7.69% |
| Q3 2021 | -12.44% |
| Q2 2021 | 15.75% |
| Q1 2021 | 0.28% |
| Q4 2020 | 45.39% |
| Q3 2020 | 35.52% |
| Q2 2020 | -41.75% |
| Q1 2020 | -9.05% |
| Q4 2019 | 16.69% |
| Q3 2019 | 6.20% |
| Q2 2019 | 2.47% |
| Q1 2019 | 13.05% |
| Q4 2018 | -2.09% |
| Q3 2018 | 17.47% |
| Q2 2018 | -18.38% |
| Q1 2018 | 28.71% |
| Q4 2017 | -9.07% |
| Q3 2017 | -0.68% |
| Q2 2017 | -0.33% |
| Q1 2017 | 12.62% |
| Q4 2016 | 4.86% |
| Q3 2016 | -7.09% |
| Q2 2016 | 2.47% |
| Q1 2016 | -5.77% |